Lack of functionally active Melan-A26-35-specific T cells in the blood of HLA-A2+ vitiligo patients

被引:5
作者
Adams, Sylvia [1 ]
Lowes, Michelle A. [2 ]
O'Neill, David W. [3 ]
Schachterle, Stephen [3 ]
Romero, Pedro [4 ]
Bhardwaj, Nina [1 ,3 ,5 ]
机构
[1] NYU, Inst Canc, Sch Med, Dept Med, New York, NY 10016 USA
[2] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10021 USA
[3] NYU, Inst Canc, Sch Med, Dept Pathol, New York, NY 10016 USA
[4] Univ Hosp CHUV, Ludwig Inst Canc Res, Div Clin Oncoimmunol, Lausanne Branch, Lausanne, Switzerland
[5] NYU, Inst Canc, Sch Med, Dept Dermatol, New York, NY 10016 USA
关键词
D O I
10.1038/jid.2008.31
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Vitiligo, a skin disorder characterized by the spontaneous destruction of melanocytes, is believed to be of autoimmune origin. We investigated the presence and functionality of CD8(+) T-cells specific for the melanocyte-associated antigens Melan-A, gp100, tyrosinase, and TRP-2 in the blood of HLA-A2(+) vitiligo patients. We enumerated antigen-specific CD8(+) T cells by major histocompatibility complex multimer staining directly ex vivo, as well as after 9 days of in vitro stimulation and assessed IFN-gamma secretion by enzyme-linked immunospot (Elispot) assay. Tyrosinase-, gp100-, or TRP-2-specific CD8(+) T cells could not be identified in the peripheral blood of individuals with vitiligo. Although Melan-A-specific T cells were detectable at levels comparable to Flu-MP-specific T cells by multimer staining, these lymphocytes did not express the skin-homing receptor cutaneous lymphocyte antigen, were phenotypically naive (CD45RA(+)), and were unresponsive in the IFN-gamma Elispot assay, suggesting that they are unlikely to be involved in the etiopathogenesis of vitiligo.
引用
收藏
页码:1977 / 1980
页数:4
相关论文
共 15 条
[1]
Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity? [J].
Garbelli, S ;
Mantovani, S ;
Palermo, B ;
Giachino, C .
PIGMENT CELL RESEARCH, 2005, 18 (04) :234-242
[2]
KEMP EH, 2001, EXPERT REV MOL MED, P1
[3]
HLA-A2 restricted, melanocyte-specific CD8+ T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1 [J].
Lang, KS ;
Caroli, CC ;
Muhm, A ;
Wernet, D ;
Moris, A ;
Schittek, B ;
Knauss-Scherwitz, E ;
Stevanovic, S ;
Rammensee, HG ;
Garbe, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 116 (06) :891-897
[4]
Direct evidence to support the role of antigen-specific CD8+ T cells in melanoma-associated vitiligo [J].
Le Gal, FA ;
Avril, MF ;
Bosq, J ;
Lefebvre, P ;
Deschemin, JC ;
Andrieu, M ;
Dore, MX ;
Guillet, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) :1464-1470
[5]
High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo [J].
Ogg, GS ;
Dunbar, PR ;
Romero, P ;
Chen, JL ;
Cerundolo, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1203-1208
[6]
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy [J].
Okamoto, T ;
Irie, RF ;
Fujii, S ;
Huang, SKS ;
Nizze, AJ ;
Morton, DL ;
Hoon, DSB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) :1034-1039
[7]
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers:: the role of cellular immunity in the etiopathogenesis of vitiligo [J].
Palermo, B ;
Campanelli, R ;
Garbelli, S ;
Mantovani, S ;
Lantelme, E ;
Brazzelli, V ;
Ardigó, M ;
Borroni, G ;
Martinetti, M ;
Badulli, C ;
Necker, A ;
Giachino, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) :326-332
[8]
Ex vivo IFN-γ secretion by circulating CD8 T lymphocytes:: Implications of a novel approach for T cell monitoring in infectious and malignant diseases [J].
Pittet, MJ ;
Zippelius, A ;
Speiser, DE ;
Assenmacher, M ;
Guillaume, P ;
Valmori, D ;
Liénard, D ;
Lejeune, F ;
Cerottini, JC ;
Romero, P .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7634-7640
[9]
High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals [J].
Pittet, MJ ;
Valmori, D ;
Dunbar, PR ;
Speiser, DE ;
Liénard, D ;
Lejeune, F ;
Fleischhauer, K ;
Cerundolo, V ;
Cerottini, JC ;
Romero, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :705-715
[10]
Mature dendritic cells prime functionally superior melan-A-specific CD8+ lymphocytes as compared with nonprofessional APC [J].
Salio, M ;
Shepherd, D ;
Dunbar, PR ;
Palmowski, M ;
Murphy, K ;
Wu, LJ ;
Cerundolo, V .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1188-1197